The QMN Weekly Bulletin

Teva Resolves 2009 Warning Letter for California Plant

Nov. 16, 2012
A A
Teva Pharmaceuticals has resolved a long-outstanding warning letter for its Irvine, Calif., plant, the company said on its recent third-quarter earnings call. Upgrades to the building and systems, as well as to manufacturing and quality processes, led to last month’s resolution of the letter, CEO and President Jeremy Levin said. The facility’s focus continues to be on producing the life-saving drugs on the FDA’s drug shortage list.
Washington Drug Letter